Center for Human Reproduction

The Center for Human Reproduction (CHR) is a world-renowned fertility center and research institute based in New York City, specializing in the treatment of complex infertility cases. The center is particularly recognized for its expertise in treating women with diminished ovarian reserve (DOR), advanced maternal age, and previous IVF failures. CHR has pioneered several clinical protocols, most notably the use of Dehydroepiandrosterone (DHEA) to improve egg quality and Platelet-Rich Plasma (PRP) for ovarian rejuvenation. As a research-driven institution, CHR frequently publishes clinical studies that influence global standards in reproductive endocrinology and assisted reproductive technology (ART).